Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Physician- and patient-based fibromyalgia criteria differ little for most patients
Key clinical point: Physician-based and patient-based reporting of fibromyalgia symptoms yield similar rates of fibromyalgia diagnosis. Major...
News
Biomarker test couldn’t predict RA transformation from undifferentiated arthritis
The multibiomarker disease activity (MBDA) score does not predict rheumatoid arthritis transformation from undifferentiated arthritis.
News
Infliximab biosimilar SB2 shows efficacy, safety similar to Remicade for RA
The investigational infliximab biosimilar drug SB2 provided efficacy and safety equivalent to the originator drug Remicade in patients with...
News
Secukinumab proves successful against psoriatic arthritis in FUTURE 2 trial
Psoriatic arthritis patients treated with 150-mg and 300-mg doses of secukinumab achieved significantly higher ACR20 responses than placebo-...
News
EULAR: Serious adverse events rise with number of biologics used in JIA
Key clinical point: JIA patients who had used more than one biologic while on methotrexate had nearly twice the rate of adverse events as did...
